Potassium Chloride for Inj. Concentrate, USP, 40 mEq (2 mEq/mL), 20 mL Single-dose Fliptop Vial, For IV use, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA
Published April 30, 2014 · Recall initiated: March 27, 2014
Summary
FDA records drug Class II recall D-1261-2014, published April 30, 2014 and initiated March 27, 2014. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 255,900 vials; Lot: Lot 22-127-DK. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate; red and black particulate within the solution and embedded within the plastic vial identified as iron oxide
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide
- Lot
- Lot 22-127-DK
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAInfant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, RxMay 31, 2017
- FDAMinibore Extension Set, 59 Inch with Spin Lock Collar, Non-DEHP, Latex-Free Intended use: For theJanuary 18, 2017
- FDAFentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL, Rx only, Hospira, Inc., LakeNovember 30, 2016
- FDASymbiq Two Channel Infuser; an Rx medical device infusion pump used to administer I.V. fluids. List numberNovember 16, 2016
- FDANon-Drowsy 24 Hour Formula Allergy Relief and Nasal Decongestant, Pseudoephedrine Sulfate, USP 240 mg ,April 30, 2014
- FDACinnamon Cookie Manjoo, 200g Net Weight. Packaged in clear plastic bag, 10 per bag. Product package labeled inApril 30, 2014
Questions about this recall
Was Potassium Chloride for Inj. Concentrate, USP, 40 mEq (2 mEq/mL), 20 mL Single-dose Fliptop Vial, For IV use, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA recalled?
Yes. FDA published recall D-1261-2014 on April 30, 2014. Reported hazard: Presence of Particulate; red and black particulate within the solution and embedded within the plastic vial identified as iron oxide
What should I do if I have this product?
Voluntary: Firm initiated · Letter